デフォルト表紙
市場調査レポート
商品コード
1317915

ドライアイ症候群市場:医薬品、製品別-2023-2030年の世界予測

Dry Eye Syndrome Market by Drug, Product - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
ドライアイ症候群市場:医薬品、製品別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ドライアイ症候群の世界市場は、2023年に43億9,790万米ドル、CAGR7.19%で大幅な成長が予測され、2030年には71億6,295万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のドライアイ症候群市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.ドライアイ症候群の世界市場規模および予測は?

2.予測期間中、世界のドライアイ症候群市場を形成するCOVID-19の阻害要因と影響は?

3.ドライアイ症候群の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.ドライアイ症候群の世界市場における競争戦略は?

5.ドライアイ症候群の世界市場における技術動向と規制の枠組みは?

6.ドライアイ症候群の世界市場における主要ベンダーの市場シェアは?

7.ドライアイ症候群の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ドライアイ疾患の罹患率の増加
      • 病気の診断と治療に対する意識の高まり
      • 世界中で高齢者人口が増加
    • 抑制要因
      • 厳格な規制プロセス
    • 機会
      • 新たな技術の開発
      • 研究開発投資の増加
    • 課題
      • 製品リコールの増加
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 ドライアイ症候群市場薬物別

  • 抗炎症薬
  • 自己血清点眼薬
  • 潤滑点眼薬

第7章 ドライアイ症候群市場:製品別

  • 目の軟膏
  • ゲル
  • 液滴
  • 液体ワイプ

第8章 南北アメリカのドライアイ症候群市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のドライアイ症候群市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのドライアイ症候群市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. DRY EYE SYNDROME MARKET RESEARCH PROCESS
  • FIGURE 2. DRY EYE SYNDROME MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2022 VS 2030 (%)
  • FIGURE 5. DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 6. DRY EYE SYNDROME MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. DRY EYE SYNDROME MARKET DYNAMICS
  • FIGURE 8. DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRY EYE SYNDROME MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRY EYE SYNDROME MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 5. DRY EYE SYNDROME MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRY EYE SYNDROME MARKET SIZE, BY AUTOLOGOUS SERUM EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRY EYE SYNDROME MARKET SIZE, BY LUBRICANT EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 9. DRY EYE SYNDROME MARKET SIZE, BY EYE OINTMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRY EYE SYNDROME MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DRY EYE SYNDROME MARKET SIZE, BY LIQUID DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRY EYE SYNDROME MARKET SIZE, BY LIQUID WIPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM DRY EYE SYNDROME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. DRY EYE SYNDROME MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 100. DRY EYE SYNDROME MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 101. DRY EYE SYNDROME MARKET LICENSE & PRICING
目次
Product Code: MRR-4348D129FA99

The Global Dry Eye Syndrome Market is forecasted to grow significantly, with a projected USD 4,397.90 million in 2023 at a CAGR of 7.19% and expected to reach a staggering USD 7,162.95 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Dry Eye Syndrome Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Dry Eye Syndrome Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug, market is studied across Anti-inflammatory Drugs, Autologous Serum Eye Drops, and Lubricant Eye Drops. The Anti-inflammatory Drugs is projected to witness significant market share during forecast period.

Based on Product, market is studied across Eye Ointment, Gel, Liquid Drops, and Liquid Wipes. The Eye Ointment is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Dry Eye Syndrome Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Dry Eye Syndrome Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Dry Eye Syndrome Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Dry Eye Syndrome Market?

4. What is the competitive strategic window for opportunities in the Global Dry Eye Syndrome Market?

5. What are the technology trends and regulatory frameworks in the Global Dry Eye Syndrome Market?

6. What is the market share of the leading vendors in the Global Dry Eye Syndrome Market?

7. What modes and strategic moves are considered suitable for entering the Global Dry Eye Syndrome Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Dry Eye Syndrome Market, by Drug, 2022 vs 2030
  • 4.3. Dry Eye Syndrome Market, by Product, 2022 vs 2030
  • 4.4. Dry Eye Syndrome Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of dry eye diseases
      • 5.1.1.2. Growing awareness regarding diagnosis and treatment of the disease
      • 5.1.1.3. Rising geriatric population across the world
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory process
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel technologies
      • 5.1.3.2. Increase in R&D investment
    • 5.1.4. Challenges
      • 5.1.4.1. Increase in product recall
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Dry Eye Syndrome Market, by Drug

  • 6.1. Introduction
  • 6.2. Anti-inflammatory Drugs
  • 6.3. Autologous Serum Eye Drops
  • 6.4. Lubricant Eye Drops

7. Dry Eye Syndrome Market, by Product

  • 7.1. Introduction
  • 7.2. Eye Ointment
  • 7.3. Gel
  • 7.4. Liquid Drops
  • 7.5. Liquid Wipes

8. Americas Dry Eye Syndrome Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dry Eye Syndrome Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dry Eye Syndrome Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing